3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

Institution: University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Project lead: DI Miriam Klausberger, Ph.D., DI Mark Dürkop, Ph.D. Project description (German): Ein SARS-CoV-2-Antikörpertest gibt Auskunft darüber, ob jemand bereits mit dem Coronavirus infiziert war oder ob im Rahmen einer Impfung Antikörper gebildet wurden. Für den Antikörpernachweis nach einer Infektion oder […]

bntx-20211231

Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications - IOS Press

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population - ScienceDirect

Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria

COVID-19 Detection - Enzo Life Sciences

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl

Breakthroughs in hepatitis C research: from discovery to cure

Houska Prize - B&C Gruppe

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

Biosensors based on potent miniprotein binder for sensitive testing of SARS- CoV‑2 variants of concern